Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 402,913
  • Shares Outstanding, K 54,301
  • Annual Sales, $ 250,010 K
  • Annual Income, $ 132,330 K
  • 60-Month Beta 0.96
  • Price/Sales 1.64
  • Price/Cash Flow 2.53
  • Price/Book 1.42
Trade VYGR with:

Options Overview Details

View History
  • Implied Volatility 82.93% ( -2.04%)
  • Historical Volatility 72.98%
  • IV Percentile 78%
  • IV Rank 38.85%
  • IV High 164.12% on 11/07/23
  • IV Low 31.35% on 11/09/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 13
  • Volume Avg (30-Day) 176
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 3,249
  • Open Int (30-Day) 3,876

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.44
  • Number of Estimates 4
  • High Estimate -0.31
  • Low Estimate -0.50
  • Prior Year 2.94
  • Growth Rate Est. (year over year) -114.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.26 +5.37%
on 04/25/24
10.66 -28.24%
on 04/01/24
-2.37 (-23.65%)
since 03/26/24
3-Month
7.08 +8.05%
on 02/13/24
10.66 -28.24%
on 04/01/24
+0.14 (+1.86%)
since 01/26/24
52-Week
6.06 +26.24%
on 11/13/23
14.34 -46.65%
on 05/22/23
+0.21 (+2.82%)
since 04/26/23

Most Recent Stories

More News
Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics: Q4 Earnings Snapshot

VYGR : 7.60 (+2.43%)
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

March S&P 500 E-Mini futures (ESH24) are trending down -0.23% this morning as investors looked ahead to the crucial monthly U.S. nonfarm payrolls report for further clues on the timing of possible interest-rate...

ESH24 : 5,101.67s (-1.01%)
WBA : 17.89 (+1.65%)
MBLY : 28.91 (-6.44%)
AAPL : 170.05 (+0.09%)
ALL : 168.95 (-1.97%)
EDV.LN : 1,705.000 (+1.07%)
LIGHT.NA : 25.020 (-11.28%)
PTON : 3.19 (+5.28%)
APLT : 4.41 (+4.26%)
IBM : 167.09 (-1.08%)
FUSN : 21.46 (+0.28%)
PLTR : 22.39 (+3.13%)
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 7.60 (+2.43%)
Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics: Q2 Earnings Snapshot

VYGR : 7.60 (+2.43%)
2 Biotech Stocks That Could Make You Richer

These biotech companies are seeing a spike in revenue growth.

VYGR : 7.60 (+2.43%)
ZYME : 8.23 (+1.48%)
Voyager Therapeutics (VYGR) Q1 Earnings and Revenues Surpass Estimates

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 1,860% and 51.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VYGR : 7.60 (+2.43%)
HUMA : 3.88 (-0.51%)
Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics: Q1 Earnings Snapshot

VYGR : 7.60 (+2.43%)
Voyager Therapeutics (VYGR) Surges 11.1%: Is This an Indication of Further Gains?

Voyager Therapeutics (VYGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

VYGR : 7.60 (+2.43%)
LEGN : 44.74 (+0.72%)
Lumos Pharma (LUMO) Reports Q1 Loss, Tops Revenue Estimates

Lumos (LUMO) delivered earnings and revenue surprises of 20.54% and 126.56%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LUMO : 2.74 (-0.59%)
VYGR : 7.60 (+2.43%)
Seattle Genetics (SGEN) Reports Q1 Loss, Lags Revenue Estimates

Seattle Genetics (SGEN) delivered earnings and revenue surprises of -13.41% and 0.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SGEN : 228.74 (-0.07%)
VYGR : 7.60 (+2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 7.80
2nd Resistance Point 7.66
1st Resistance Point 7.54
Last Price 7.60
1st Support Level 7.28
2nd Support Level 7.14
3rd Support Level 7.02

See More

52-Week High 14.34
Fibonacci 61.8% 11.18
Fibonacci 50% 10.20
Fibonacci 38.2% 9.22
Last Price 7.60
52-Week Low 6.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar